Tennessee Attorney General Jonathan Skrmetti this week led a 38-state and territory bipartisan coalition requesting that the Food and Drug Administration (FDA) take swift action against bad actors who are endangering consumers with counterfeit and unsafe forms of the weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro, and Zepbound (GLP-1 drugs).
“Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes,” said Attorney General Jonathan Skrmetti. “These counterfeit or copycat drugs can be contaminated through shady supply chains running from China, Turkey, and other overseas suppliers, or they can contain entirely different drugs manufactured and packaged to look like GLP-1 drugs. We are asking the FDA to lead efforts to safeguard our American supply chain and to work with other federal and state agencies to stop bad actors from producing counterfeit drugs.”